Search results
Dynavax Technologies Corp. [NASDAQ: DVAX] Sees Decrease in Stock Value – Knox Daily
Knox Daily· 1 day agoEarlier on August 06, 2021, Goldman initiated its rating. Their recommendation was “a Buy” for DVAX stock. Analyzing DVAX Stock ...
Dynavax Technologies Corp. (DVAX) Shares Soar Above 1-Year High – News Heater
NewsHeater· 1 week agoDynavax Technologies Corp. (NASDAQ: DVAX)’s stock price has gone rise by 3.85 in comparison to its previous close of 11.37, however, the company has experienced ...
Los Angeles Capital Management LLC Trims Stake in Dynavax Technologies Co. (NASDAQ:DVAX)
ETF DAILY NEWS· 20 hours ago(NASDAQ:DVAX – Free Report) by 19.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 63,774 shares ...
Dynavax Technologies Corporation (NASDAQ:DVAX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoDynavax Technologies Corporation (NASDAQ:DVAX) Q1 2024 Earnings Call Transcript May 8, 2024 Dynavax...
Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 2 days agoDynavax Technologies (DVAX) delivered earnings and revenue surprises of -40% and 2.29%,...
Dynavax Technologies Corp. (DVAX) gets rating Initiated from Goldman – Knox Daily
Knox Daily· 5 days agoA total of 1.5 million shares were traded, compared to the trading of 1.76 million shares in the previous session. Levels Of Support And Resistance For DVAX Stock ...
Dynavax Technologies: Q1 Earnings Snapshot
San Francisco Chronicle· 2 days agoEMERYVILLE, Calif. (AP) — EMERYVILLE, Calif. (AP) — Dynavax Technologies Corp. (DVAX)...
Biotech Stocks Facing FDA Decision In May 2024
RTT News· 1 week agoAs April comes to an end, attention shifts to biotech stocks poised for regulatory events in May. The FDA approved eight novel drugs last May, contributing to a total of 55 approvals in 2023 ...